FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890749675> ?p ?o ?g. }

• W2890749675 endingPage "650" @default.
• W2890749675 startingPage "640" @default.
• W2890749675 abstract "The reduction of visible particles in injectable products is an important element in the consistent delivery of high-quality parenteral products. An important part of this effort is the control of particles that may emanate from the primary packaging materials. The Parenteral Drug Association (PDA), with the support of the Pharmaceutical Manufacturers Forum (PMF), has undertaken the task of developing test methods to assess the cleanliness of primary packaging components used in the manufacturing of sterile injectable products. Further work is focused on end-to-end analysis of the supply chain to identify additional points where particles may enter the finished product workflow. This includes shipment, receipt, transfer, and fill and finishing operations. This information and appropriate corrective actions and control methods, coupled with appropriate patient risk-based acceptance limits, are intended to provide better and more consistent supply of injectable products that meet current compendial and good manufacturing practice (GMP) expectations. Aligning control limits between supplier and pharmaceutical manufacturers will offer further improvement. This paper describes the formation of a task force to address these needs and current progress to date.LAY ABSTRACT: Visible particles must be controlled in parenteral products. Such particles come from many sources including the primary packaging materials. The Parenteral Drug Association (PDA), with the support of the Pharmaceutical Manufacturers Forum (PMF), has formed a task force to review and improve particle measurement methods and perform an end-to-end analysis of how particles may enter into parenteral products. These activities are intended to lead to more consistent control limits for visible particles and ultimately more consistent supply of high quality injectable products." @default.
• W2890749675 created "2018-09-27" @default.
• W2890749675 creator A5015174586 @default.
• W2890749675 creator A5015594708 @default.
• W2890749675 creator A5019441628 @default.
• W2890749675 creator A5026944423 @default.
• W2890749675 creator A5036095059 @default.
• W2890749675 creator A5039916453 @default.
• W2890749675 creator A5054616757 @default.
• W2890749675 creator A5055276931 @default.
• W2890749675 creator A5065317149 @default.
• W2890749675 creator A5071398251 @default.
• W2890749675 creator A5075229097 @default.
• W2890749675 creator A5091476631 @default.
• W2890749675 date "2018-01-01" @default.
• W2890749675 modified "2023-09-26" @default.
• W2890749675 title "Achieving “Zero” Defects for Visible Particles in Injectables" @default.
• W2890749675 cites W1550208237 @default.
• W2890749675 cites W2336388276 @default.
• W2890749675 cites W2395396418 @default.
• W2890749675 cites W1894301051 @default.
• W2890749675 doi "https://doi.org/10.5731/pdajpst.2018.009027" @default.
• W2890749675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30232141" @default.
• W2890749675 hasPublicationYear "2018" @default.
• W2890749675 type Work @default.
• W2890749675 sameAs 2890749675 @default.
• W2890749675 citedByCount "4" @default.
• W2890749675 countsByYear W28907496752019 @default.
• W2890749675 countsByYear W28907496752020 @default.
• W2890749675 countsByYear W28907496752022 @default.
• W2890749675 crossrefType "journal-article" @default.
• W2890749675 hasAuthorship W2890749675A5015174586 @default.
• W2890749675 hasAuthorship W2890749675A5015594708 @default.
• W2890749675 hasAuthorship W2890749675A5019441628 @default.
• W2890749675 hasAuthorship W2890749675A5026944423 @default.
• W2890749675 hasAuthorship W2890749675A5036095059 @default.
• W2890749675 hasAuthorship W2890749675A5039916453 @default.
• W2890749675 hasAuthorship W2890749675A5054616757 @default.
• W2890749675 hasAuthorship W2890749675A5055276931 @default.
• W2890749675 hasAuthorship W2890749675A5065317149 @default.
• W2890749675 hasAuthorship W2890749675A5071398251 @default.
• W2890749675 hasAuthorship W2890749675A5075229097 @default.
• W2890749675 hasAuthorship W2890749675A5091476631 @default.
• W2890749675 hasConcept C108713360 @default.
• W2890749675 hasConcept C111472728 @default.
• W2890749675 hasConcept C112930515 @default.
• W2890749675 hasConcept C117671659 @default.
• W2890749675 hasConcept C127413603 @default.
• W2890749675 hasConcept C136764020 @default.
• W2890749675 hasConcept C138885662 @default.
• W2890749675 hasConcept C144133560 @default.
• W2890749675 hasConcept C154945302 @default.
• W2890749675 hasConcept C162853370 @default.
• W2890749675 hasConcept C177212765 @default.
• W2890749675 hasConcept C201995342 @default.
• W2890749675 hasConcept C21547014 @default.
• W2890749675 hasConcept C2524010 @default.
• W2890749675 hasConcept C2775924081 @default.
• W2890749675 hasConcept C2778938233 @default.
• W2890749675 hasConcept C2778979077 @default.
• W2890749675 hasConcept C2779530757 @default.
• W2890749675 hasConcept C2779709869 @default.
• W2890749675 hasConcept C2780451532 @default.
• W2890749675 hasConcept C33923547 @default.
• W2890749675 hasConcept C41008148 @default.
• W2890749675 hasConcept C71924100 @default.
• W2890749675 hasConcept C77088390 @default.
• W2890749675 hasConcept C90673727 @default.
• W2890749675 hasConcept C98274493 @default.
• W2890749675 hasConceptScore W2890749675C108713360 @default.
• W2890749675 hasConceptScore W2890749675C111472728 @default.
• W2890749675 hasConceptScore W2890749675C112930515 @default.
• W2890749675 hasConceptScore W2890749675C117671659 @default.
• W2890749675 hasConceptScore W2890749675C127413603 @default.
• W2890749675 hasConceptScore W2890749675C136764020 @default.
• W2890749675 hasConceptScore W2890749675C138885662 @default.
• W2890749675 hasConceptScore W2890749675C144133560 @default.
• W2890749675 hasConceptScore W2890749675C154945302 @default.
• W2890749675 hasConceptScore W2890749675C162853370 @default.
• W2890749675 hasConceptScore W2890749675C177212765 @default.
• W2890749675 hasConceptScore W2890749675C201995342 @default.
• W2890749675 hasConceptScore W2890749675C21547014 @default.
• W2890749675 hasConceptScore W2890749675C2524010 @default.
• W2890749675 hasConceptScore W2890749675C2775924081 @default.
• W2890749675 hasConceptScore W2890749675C2778938233 @default.
• W2890749675 hasConceptScore W2890749675C2778979077 @default.
• W2890749675 hasConceptScore W2890749675C2779530757 @default.
• W2890749675 hasConceptScore W2890749675C2779709869 @default.
• W2890749675 hasConceptScore W2890749675C2780451532 @default.
• W2890749675 hasConceptScore W2890749675C33923547 @default.
• W2890749675 hasConceptScore W2890749675C41008148 @default.
• W2890749675 hasConceptScore W2890749675C71924100 @default.
• W2890749675 hasConceptScore W2890749675C77088390 @default.
• W2890749675 hasConceptScore W2890749675C90673727 @default.
• W2890749675 hasConceptScore W2890749675C98274493 @default.
• W2890749675 hasIssue "6" @default.
• W2890749675 hasLocation W28907496751 @default.
• W2890749675 hasLocation W28907496752 @default.

• next